felix chem retatrutide Triple Agonist (GLP-1/GIP/GCG) The next generation of weight
Description
Retrieved from Hinnen, D
Some are approved for type 2 diabetes, while others are approved for chronic weight management in patients with a qualifying BMI
PubMed: 41549912 Kreider RB, et al
The combination makes pharmacological sense
First, the growing recognition that BMI is a flawed metric is driving conversations about alternative eligibility criteria
